We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

256 hedge funds and large institutions have $5.32B invested in IVERIC bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 1540 (+25)

129% more call options, than puts

Call options by funds: $538M | Put options by funds: $234M

49% more capital invested

Capital invested by funds: $3.58B → $5.32B (+$1.74B)

45% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 73

15% more funds holding

Funds holding: 223256 (+33)

16% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 69

Holders
256
Holders Change
+33
Holders Change %
+14.8%
% of All Funds
4.02%
Holding in Top 10
40
Holding in Top 10 Change
+25
Holding in Top 10 Change %
+166.67%
% of All Funds
0.63%
New
106
Increased
58
Reduced
69
Closed
73
Calls
$538M
Puts
$234M
Net Calls
+$303M
Net Calls Change
+$293M
Name Holding Trade Value Shares
Change
Change in
Stake
WIC
51
Water Island Capital
New York
$19.8M +$17.8M +503,196 New
PCM
52
Pentwater Capital Management
Florida
$19.7M +$17.6M +500,000 New
American Century Companies
53
American Century Companies
Missouri
$18.9M -$126M -3,565,655 -88%
Qube Research & Technologies (QRT)
54
Qube Research & Technologies (QRT)
United Kingdom
$18M +$16.1M +456,296 New
Jane Street
55
Jane Street
New York
$17.9M +$3.05M +86,523 +24%
AA
56
AQR Arbitrage
Connecticut
$17.7M +$15.9M +450,361 New
SCS
57
Syquant Capital SAS
France
$16M +$14.4M +406,686 New
VI
58
Versor Investments
New York
$16M +$14.3M +405,945 New
JP Morgan Chase
59
JP Morgan Chase
New York
$15.9M -$13.4M -379,019 -48%
PMAM
60
Picton Mahoney Asset Management
Ontario, Canada
$15.8M +$14.1M +400,474 New
HSBC Holdings
61
HSBC Holdings
United Kingdom
$15.2M +$10.5M +297,414 +340%
CCM
62
Chicago Capital Management
Illinois
$14.1M +$12.7M +359,561 New
NIP
63
Nicholas Investment Partners
California
$12.8M +$11.5M +325,548 New
PCM
64
Prelude Capital Management
New York
$12.8M +$10.9M +309,573 +2,033%
PAMP
65
Polar Asset Management Partners
Ontario, Canada
$12.5M -$11.1K -315 -0.1%
CS
66
Candriam SCA
Luxembourg
$12.4M -$21.7M -615,098 -66%
TS
67
Twin Securities
New York
$12.3M +$11M +311,549 New
UBS AM
68
UBS AM
Illinois
$12.1M
SB
69
Samsara BioCapital
California
$12.1M -$13.4M -378,684 -55%
GL
70
Governors Lane
New York
$11.9M +$10.7M +303,500 New
Citadel Advisors
71
Citadel Advisors
Florida
$11.8M +$9.81M +277,924 +1,271%
Citigroup
72
Citigroup
New York
$11.7M +$1.2M +33,992 +13%
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$11.2M +$2.81M +79,596 +39%
SAM
74
Silphium Asset Management
United Kingdom
$10.8M +$9.71M +275,000 New
NYLIM
75
New York Life Investment Management
New York
$10.8M +$9.69M +274,472 New

ISEE Hedge Fund Activity: Q2 2023 in Review

256 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2023, worth a combined $5.32B — up 49% from $3.58B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new ISEE positions and 73 closed out — a net gain of 33 holders — while 58 added to existing stakes and 69 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $206M. The largest seller was T. Rowe Price Associates, cutting an estimated $238M.

  • 256 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2023, up from 223 in Q1 2023.
  • Funds reported $5.32B of IVERIC bio, Inc. Common Stock stock for Q2 2023, up 49% quarter-over-quarter.
  • 106 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2023 and 73 closed out, a net change of +33 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2023 was UBS O'Connor, an estimated $206M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2023 was T. Rowe Price Associates, an estimated $238M sold.

Based on aggregated 13F filings for Q2 2023.